Sphingolipidoses
Sphingolipidoses | |
---|---|
Diagram showing some of the sphingolipidoses
|
|
Classification and external resources | |
Specialty | Lua error in Module:Wikidata at line 446: attempt to index field 'wikibase' (a nil value). |
ICD-10 | E75.3 |
ICD-9-CM | 272.7 |
DiseasesDB | 33438 |
Patient UK | Sphingolipidoses |
MeSH | D013106 |
Sphingolipidoses (singular "sphingolipidosis") are a class of lipid storage disorders relating to sphingolipid metabolism. The main members of this group are Niemann-Pick disease, Fabry disease, Krabbe disease, Gaucher disease, Tay-Sachs disease and Metachromatic leukodystrophy. They are generally inherited in an autosomal recessive fashion, but notably Fabry disease is X-linked recessive. Taken together, sphingolipidoses have an incidence of approximately 1 in 10,000, but substantially more in certain populations such as Ashkenazi Jews. Enzyme replacement therapy is available to treat mainly Fabry disease and Gaucher disease, and people with these types of sphingolipidoses may live well into adulthood. The other types are generally fatal by age 1 to 5 years for infantile forms, but progression may be mild for juvenile- or adult-onset forms.
Contents
Accumulated products
Overview
Table
Disease | Deficient enzyme[1] | Accumulated products[1] | Symptoms[1] | Inheritance[1] | Incidence | Generally accepted treatments | Prognosis |
---|---|---|---|---|---|---|---|
Niemann-Pick disease | Sphingomyelinase | Sphingomyelin in brain and RBCs |
|
Autosomal recessive | 1 in 100,000[2] | Limited | Usually fatal by the age of approx 1.5 years.[3] |
Fabry disease | α-galactosidase A | Glycolipids, particularly ceramide trihexoside, in brain, heart, kidney |
|
X-linked[4] | Between 1 in 40,000 to 1 in 120,000 live births for males.[5] | Enzyme replacement therapy (but expensive) | Life expectancy among males of approximately 60 years.[6] |
Krabbe disease | Galactocerebrosidase | Glycolipids, particularly galactocerebroside, in oligodendrocytes |
|
Autosomal recessive | About 1 in 100,000 births.[7] | Bone marrow transplant (high risk, potential failure, effectively provides enzyme replacement to the central nervous system from six months post-transplant, if done in the earliest stages; less effective enzyme replacement provision for the peripheral nervous system) | Untransplanted, and in the case of a failed transplant, generally fatal before age 2 for infants |
Gaucher disease | Glucocerebrosidase | Glucocerebrosides in RBCs, liver and spleen |
|
Autosomal recessive | About 1 in 20,000 live births,[8] more among Ashkenazi Jews | Enzyme replacement therapy (but expensive) | May live well into adulthood |
Tay-Sachs disease | Hexosaminidase A | GM2 gangliosides in neurons |
|
Autosomal recessive | Approximately 1 in 320,000 newborns in the general population,[9] more in Ashkenazi Jews | None | Death by approx. 4 years for infantile Tay–Sachs [10] |
Metachromatic leukodystrophy (MLD) | Arylsulfatase A or prosaposin | Sulfatide compounds in neural tissue | Demyelinisation in CNS and PNS:
|
Autosomal recessive[11] | 1 in 40,000 to 1 in 160,000[12] | Bone marrow transplant (high risk, potential failure, effectively provides enzyme replacement to the central nervous system from six months post-transplant, if done in the earliest stages; less effective enzyme replacement provision for the peripheral nervous system) | Untransplanted, and in the case of a failed transplant, death by approx. 5 years for infantile MLD |
Metabolic pathways
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
- Sphingolipidoses at the US National Library of Medicine Medical Subject Headings (MeSH)
- -382402491 at GPnotebook
<templatestyles src="Asbox/styles.css"></templatestyles>
- ↑ 1.0 1.1 1.2 1.3 If not otherwise specified, reference is: Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Niemann-Pick disease from Genetics Home Reference. Reviewed: January 2008. Based on an incidence in a general population of 1 in 250,000 for types A and B and 1 in 150,000 for type C
- ↑ NINDS Niemann-Pick Disease Information Page at the National Institute of Neurological Disorders and Stroke. Last updated October 6, 2011
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Gaucher Disease at National Gaucher Foundation. Retrieved June 2012
- ↑ GM2 Gangliosidoses - Introduction And Epidemiology at Medscape. Author: David H Tegay. Updated: Mar 9, 2012
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Metachromatic leukodystrophy at Genetics Home Reference. Reviewed September 2007